<p>Proportion of Japanese outpatients filling prescriptions for long-term medication regimens</p>

Abstract

Aim: Our study aimed to clarify how long outpatients with chronic diseases such as hypertension continuously fill prescriptions for the same medications as those prescribed initially and how many medications they take over the long term. Methods: Medication records from April 1, 2016 to March 31, 2017 with total days between initial and final dispensation date ≥330 days and total days of medication supplies ≥180 days were extracted from an electronic database in a Japanese community pharmacy chain. The continuity of refilling medications over 1 year (ie, medication fill adherence) was measured using the medication possession ratio (MPR). Results: A total of 34,549 outpatients received long-term medications under the above conditions (4.4% of all patients in the database). Mean age was 66.0±17.4 years; 63.1% were ≥65 years. The mean number of medications prescribed per patient was 3.2±2.3. More than one-fifth of patients (22.6%) were taking ≥5 medications. The mean MPR for patients overall was 93.6±11.2%; 87.2% of patients had an MPR ≥80% but <110%. Amlodipine besylate, an antihypertensive, was the most commonly prescribed drug (n=5,537 patients). Conclusion: Outpatients that received long-term medications with no change in prescription had an MPR >90% for around 3 medications. It can be reasonably assumed that these patients could receive a longer-term medication supply with the partial fills based on a physician’s instruction (“Bunkatu Chozai” in Japanese). This longer-term supply would be similar to a basic prescription refill, but would require a physician’s signature allowing for partial refills rather than a new prescription for each refill.

Prevalence of type 2 diabetes by age, sex and geographical area among two million public assistance recipients in Japan: a cross-sectional study using a nationally representative claims database

“…Thus, the prevalence could be underestimated because some patients with diabetes may not visit healthcare facilities every month. According to a report using an electronic database of Japanese community pharmacy chains, the average number of prescription days per prescription for outpatients with chronic diseases was Metformin hydrochloride 38.1 ± 15.0 days and Sitagliptin phosphate hydrate 36.7 ± 15.5 days 34 . According to a 2019 survey report on hypoglycemic drugs by the MHLW, about 70% were within 30 prescription days 35 .…”

Association of drugs with special caution in the guidelines with falls: A case–control and case–crossover study in Japan

“…Oral medications are classified according to the YJ code classification used by the Japanese Ministry of Health, Labor and Welfare 23,24 . Based on the examinations of the two authors, oral medications in the patient records were classified according to the “Japanese guidelines for medical treatment and its safety in the elderly 2015”.…”

Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

“…Under the Pharmaceutical Benefits Scheme regulations (for eligible drugs for chronic conditions, such as hypertension), prescription duration is limited to 6 months, and dispensing duration is limited to 30 days [8]. Since September 1st 2023 some chronic disease medications (including those for hypertension) are exempt and can be prescribed with prescription durations of up to 12 months and dispensing durations of up to 60 days [8].…”